Functional and structural studies of the SARS-CoV-2 accessory protein Nsp8 for novel antiviral therapies
- Funded by Academy of Finland
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$460,361.66Funder
Academy of FinlandPrincipal Investigator
Matjaz BarboricResearch Location
FinlandLead Research Institution
University of HelsinkiResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The lack of therapies for COVID-19 calls for detailed studies of the life cycle of SARS-CoV-2, the disease's causative agent. Recent studies have revealed how the virus could reshape the host cell and interact with cellular proteins for optimal replication. Intriguingly, an essential viral accessory protein Nsp8 interacts with LARP7 and MePCE proteins that play important gene regulatory roles in human cells, potentially explaining how the virus rewires the cells and hides from our immune system. We will use multi-disciplinary approaches to shed a light on this important biology of SARS-CoV-2. We shall also solve the three-dimensional structure of Nsp8 bound to LARP7, and identify compounds that interfere with this interaction. In conclusion, our studies shall reveal how SARS-CoV-2 manipulates human cells for its own benefit. Moreover, they shall yield compounds blocking viral replication, paving the way to the urgently needed COVID-19 therapeutics.